In T-cell acute lymphoblastic leukemia (T-ALL) cell line HPB-ALL, glutamine upregulates UCP2, and UCP2 silencing leads to TCA intermediate accumulation in the matrix, reducing OCR and cell proliferation rates [157]. Here, UCP2 is linked to acute lymphoblastic leukemia.